How Aspirin Inhibits Platelet Function to Cause Bleeding
Aspirin causes bleeding primarily by irreversibly inhibiting cyclooxygenase-1 (COX-1) in platelets, blocking thromboxane A2 production. Thromboxane A2 normally triggers platelet aggregation and vasoconstriction to form clots at injury sites. Without it, platelets can't clump effectively, prolonging bleeding time—often by 2-5 times normal levels after a single dose.[1][2]
This effect lasts 7-10 days, matching platelet lifespan, as megakaryocytes can't regenerate COX-1 while aspirin circulates. Low-dose aspirin (81 mg daily) targets this selectively without much systemic COX inhibition.
Why GI Bleeding Is Common
Aspirin also suppresses COX-1 in stomach mucosa, reducing protective prostaglandins like PGE2. These normally boost mucus and bicarbonate secretion while inhibiting acid. The result: eroded mucosal barriers, ulcers, and bleeding—accounting for up to 30% of upper GI bleeds in users.[3][4]
Risk rises with higher doses (>325 mg), concurrent NSAIDs/steroids, H. pylori infection, or age >65.
Does Aspirin Affect Clotting Beyond Platelets?
Minimal direct impact on coagulation factors or fibrin formation—bleeding stems from poor primary hemostasis (platelet plug failure), not fibrinolysis or clotting cascade defects. It mildly prolongs bleeding time but doesn't alter PT/PTT in standard tests.[1][5]
High doses can indirectly enhance fibrinolysis by reducing plasminogen activator inhibitor-1, but this is secondary.
How Long Do Effects Last and When Is Risk Highest?
Antiplatelet effects peak within hours and persist until new platelets form (full recovery in 10-14 days). Surgical bleeding risk is highest if taken within 5-7 days pre-op; guidelines recommend stopping 7 days before elective procedures.[6]
Reversibility is limited—no antidote; platelet transfusion provides new, functional platelets.
Who Faces Highest Bleeding Risk?
- High-risk groups: Ulcer history, anticoagulants (e.g., warfarin), clopidogrel combo, or alcohol use—odds of major bleed double.[4]
- Dose-dependent: Low-dose for cardioprotection cuts MI/stroke risk with 1-2/1000 annual bleed rate; OTC pain doses elevate GI risk 2-4 fold.[2][7]
- Alternatives for caution: Enteric-coated or buffered aspirin reduces GI irritation but not systemic platelet effects.
[1] PubMed: Aspirin's mechanism in platelets
[2] NEJM: Antiplatelet therapy and bleeding
[3] Gastroenterology: Aspirin and GI injury
[4] AHA Guidelines: Aspirin in CVD
[5] Blood Journal: Hemostasis overview
[6] ACC: Perioperative management
[7] BMJ: Aspirin dose-risk meta-analysis